Skip to main content

Blood and Urinary Tests in Stone Formers

  • Chapter
  • First Online:
Urinary Tract Stone Disease

Abstract

Kidney stone disease is highly prevalent, has a rising incidence, and a high recurrence rate. Stone events greatly impact quality of life of patients and pose a great financial burden on society. Over several decades, the surgical treatment of stone disease has advanced significantly. While surgical technique has evolved, evidence demonstrates medical therapy decreases stone recurrence rates and prevention should not be overshadowed by surgical advances. A thorough metabolic evaluation of stone formers helps guide therapy for prevention. Herein we review the specific blood and urine tests that can be done in stone formers to identify specific treatable metabolic abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1995;98:50.

    Article  CAS  PubMed  Google Scholar 

  2. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817.

    Article  PubMed  Google Scholar 

  3. Heilberg IP, Schor N. Renal stone disease: causes, evaluation, and medical treatment. Arq Bras Endocrinol Metab. 2006;50:823.

    Article  Google Scholar 

  4. Scales CD, Curtis LH, Norris RD, et al. Changing gender prevalence of stone disease. J Urol. 2007;177:979.

    Article  PubMed  Google Scholar 

  5. Prezioso D, Di Martino M, Galasso R, et al. Laboratory assessment. Urol Int. 2007;79:20.

    Article  PubMed  Google Scholar 

  6. Odvina CV, Pak CYC. Medical evaluation of stone disease. In: Stoller ML, Men MV, eds. Current Clinical Urology. Urinary Stone Disease: A Practical Guide to Medical and Surgical Management, vol. 1. Totowa: Humana; 2007.

    Google Scholar 

  7. Pearle MS, Calhoun EA, Curha GC, et al. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848.

    Article  PubMed  Google Scholar 

  8. Lotan Y, Cadeddu JA, Pearle MS. International comparison of cost effectiveness of medical management strategies for nephrolithiasis. Urol Res. 2005;33:223.

    Article  PubMed  Google Scholar 

  9. Begun FP, Foley WD, Peterson A, et al. Patient evaluation laboratory and imaging studies. In: Resnick M, ed. The Urologic Clinics of North America, Urolithiasis, vol. 24. Philadelphia: W.B. Saunders; 1997:97–116.

    Google Scholar 

  10. Preminger GM. Medical evaluation and treatment of nephrolithiasis. Semin Urol. 1994;12:51.

    CAS  PubMed  Google Scholar 

  11. Pak CYC, Britton F, Peterson R, et al. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med. 1980;69:19.

    Article  CAS  PubMed  Google Scholar 

  12. DeFoor W, Asplin J, Jackson E, et al. Urinary metabolic evaluations in normal and stone forming children. J Urol. 2006;176:1793.

    Article  PubMed  Google Scholar 

  13. DeFoor W, Minevich E, Jackson E, et al. Urinary metabolic evaluations in solitary and recurrent stone forming children. J Urol. 2008;179:2369.

    Article  PubMed  Google Scholar 

  14. Pak CYC, Peterson R, Poindexter JR. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol. 2001;165:378.

    Article  CAS  PubMed  Google Scholar 

  15. Parks JH, Goldfisher E, Asplin JR, et al. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002;167:1607.

    Article  PubMed  Google Scholar 

  16. Porena M, Guiggi P, Micheli C. Prevention of stone disease. Urol Int. 2007;79:37.

    Article  PubMed  Google Scholar 

  17. Leumann E, Hoppe B. The primary hyperoxalurias. J Am Soc Nephrol. 2001;12:1986.

    CAS  PubMed  Google Scholar 

  18. Seltzer MA, Low RK, McDonald M, et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol. 1996;156:907.

    Article  CAS  PubMed  Google Scholar 

  19. Coe FL, Kavlach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974; 291:1344.

    Article  CAS  PubMed  Google Scholar 

  20. Hesse A, Vahlensieck W. Loading tests for diagnosis of metabolic anomalies in urinary stone formers. Int Urol Nephrol. 1986;18:45.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brian R. Matlaga .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer London

About this chapter

Cite this chapter

Semins, M.J., Matlaga, B.R. (2010). Blood and Urinary Tests in Stone Formers. In: Rao, N., Preminger, G., Kavanagh, J. (eds) Urinary Tract Stone Disease. Springer, London. https://doi.org/10.1007/978-1-84800-362-0_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-362-0_31

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-361-3

  • Online ISBN: 978-1-84800-362-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics